LOC728514 Inhibitors
Staurosporine, due to its broad-spectrum kinase inhibition, can affect multiple signaling pathways, potentially intersecting with those regulated by LOC728514. Trichostatin A and Bortezomib can alter gene expression and protein stability, respectively, which can indirectly impact the function or levels of LOC728514. Thapsigargin, by disrupting calcium homeostasis, can influence any calcium-dependent role of LOC728514. PD0325901 and LY294002 are pathway-specific inhibitors that target the MAPK/ERK and PI3K/Akt pathways, respectively, which are common pathways in cell signaling that LOC728514 may be associated with.
The metabolic inhibitor 2-Deoxy-D-glucose affects cellular energy pathways, potentially impacting any metabolic role of LOC728514. Cyclopamine and Y-27632 can influence developmental pathways and cytoskeletal organization, respectively, which may be relevant to LOC728514's function if it is involved in these cellular aspects. MG-132 and Tunicamycin can affect protein turnover and folding, potentially impacting LOC728514 directly if it is a substrate for these cellular processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A non-selective protein kinase inhibitor, which can modulate multiple cell signaling pathways, potentially affecting those regulated by LOC728514. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can alter gene expression, which may affect LOC728514 expression or function indirectly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect protein degradation pathways, potentially altering the turnover of LOC728514 or its regulatory proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which can disrupt calcium homeostasis, indirectly influencing LOC728514's function if it is calcium-dependent. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can disrupt the PI3K/Akt signaling pathway, potentially affecting LOC728514's role if it is involved in cell survival or growth signaling. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glycolysis inhibitor that can alter cellular metabolism, potentially influencing LOC728514 if it is involved in metabolic regulation. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that can alter cellular growth and differentiation, potentially affecting LOC728514's role if it is part of this pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that can interfere with cytoskeleton organization, potentially affecting LOC728514 if it plays a role in cell shape or motility. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
An inhibitor of the ubiquitin-proteasome pathway, which can affect protein turnover and thus potentially influence LOC728514 function. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
An inhibitor of Rac1, which can modulate actin cytoskeleton organization and cell migration, potentially affecting LOC728514's role if it is involved in these processes. | ||||||